TY - JOUR
KW - Administration, Inhalation
KW - Adrenal Cortex Hormones
KW - Adrenergic beta-2 Receptor Agonists/therapeutic use
KW - Bronchodilator Agents
KW - Drug Therapy, Combination
KW - Humans
KW - Middle Aged
KW - Muscarinic Antagonists/therapeutic use
KW - *Pneumonia/epidemiology/etiology
KW - *Pulmonary Disease, Chronic Obstructive/complications
KW - COPD exacerbations
KW - Databases
KW - long-acting bronchodilators
KW - new user cohort design
KW - observational research
KW - pneumonia
KW - real-world evidence
AU - S. Suissa
AU - S. Dell'Aniello
AU - P. Ernst
AD - Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Québec, Canada.
Departments of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Québec, Canada.
AN - 35392746
BT - Copd
DO - 10.1080/15412555.2022.2045265
DP - NLM
ET - 2022/04/09
LA - eng
M1 - 1
N1 - 1541-2563
Suissa, Samy
Orcid: 0000-0002-1281-5296
Dell'Aniello, Sophie
Ernst, Pierre
Orcid: 0000-0001-9983-3608
Journal Article
England
COPD. 2022;19(1):133-141. doi: 10.1080/15412555.2022.2045265.
PY - 2022
SN - 1541-2563
SP - 133
EP - 141
T2 - Copd
TI - Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice
VL - 19
ER -